Jetcon Corporation Limited (JMSE:JETCON)
Jamaica · Delayed Price · Currency is JMD 2.000
+0.300 (17.65%)
At close: Aug 4, 2025
Intercept Pharmaceuticals Balance Sheet
Financials in millions JMD. Fiscal year is January - December.
Millions JMD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 10.23 | 3.28 | 9.48 | 6.54 | 53.67 | 26.36 | Upgrade |
Cash & Short-Term Investments | 10.23 | 3.28 | 9.48 | 6.54 | 53.67 | 26.36 | Upgrade |
Cash Growth | 224.44% | -65.35% | 45.00% | -87.82% | 103.64% | 146.90% | Upgrade |
Accounts Receivable | 162.23 | 19.16 | 17.12 | 14.35 | 16.64 | 15.39 | Upgrade |
Other Receivables | 3.97 | 17.61 | 11.96 | 15.08 | 11.93 | 27.43 | Upgrade |
Receivables | 166.19 | 36.76 | 29.09 | 29.42 | 28.58 | 42.82 | Upgrade |
Inventory | 301.17 | 276.31 | 417.8 | 392.71 | 447.1 | 391.86 | Upgrade |
Prepaid Expenses | - | 2.35 | 1.14 | 1.06 | 1.37 | 0.86 | Upgrade |
Other Current Assets | 20.35 | 102.09 | 51.92 | 50.65 | 43.87 | 10.23 | Upgrade |
Total Current Assets | 497.94 | 420.8 | 509.43 | 480.38 | 574.59 | 472.13 | Upgrade |
Property, Plant & Equipment | 410.01 | 410.61 | 158.08 | 161.37 | 172.96 | 177.74 | Upgrade |
Long-Term Investments | 0.04 | 0.04 | 0.05 | 0.09 | 0.08 | 0.07 | Upgrade |
Total Assets | 907.99 | 831.45 | 667.56 | 641.83 | 747.63 | 649.94 | Upgrade |
Accounts Payable | - | 31.48 | 25.95 | 11.44 | 133.43 | 30.66 | Upgrade |
Accrued Expenses | - | 11.69 | 4.76 | 7.71 | 7.6 | 1.82 | Upgrade |
Short-Term Debt | 29.09 | - | 2.2 | 1.3 | 0.35 | - | Upgrade |
Current Portion of Long-Term Debt | - | - | - | - | 0.33 | 10.38 | Upgrade |
Current Portion of Leases | - | - | - | 9.48 | 15.36 | 15.36 | Upgrade |
Current Income Taxes Payable | - | - | - | 4 | 1.13 | - | Upgrade |
Other Current Liabilities | 52.08 | 53.29 | 59.66 | 28.36 | 26.41 | 21.46 | Upgrade |
Total Current Liabilities | 81.17 | 96.46 | 92.56 | 62.28 | 184.61 | 79.67 | Upgrade |
Long-Term Debt | 50 | - | - | - | - | 6.88 | Upgrade |
Long-Term Leases | - | - | - | - | 7.01 | 22.81 | Upgrade |
Long-Term Deferred Tax Liabilities | 58.56 | 58.56 | - | - | - | - | Upgrade |
Total Liabilities | 189.73 | 155.03 | 92.56 | 62.28 | 191.62 | 109.37 | Upgrade |
Common Stock | 88.82 | 88.82 | 88.82 | 88.82 | 88.82 | 88.82 | Upgrade |
Retained Earnings | 437.01 | 395.17 | 469.42 | 473.94 | 450.41 | 434.98 | Upgrade |
Comprehensive Income & Other | 192.44 | 192.44 | 16.76 | 16.8 | 16.79 | 16.78 | Upgrade |
Shareholders' Equity | 718.26 | 676.42 | 575 | 579.55 | 556.01 | 540.58 | Upgrade |
Total Liabilities & Equity | 907.99 | 831.45 | 667.56 | 641.83 | 747.63 | 649.94 | Upgrade |
Total Debt | 79.09 | - | 2.2 | 10.77 | 23.04 | 55.43 | Upgrade |
Net Cash (Debt) | -68.86 | 3.28 | 7.28 | -4.24 | 30.63 | -29.07 | Upgrade |
Net Cash Growth | - | -54.90% | - | - | - | - | Upgrade |
Net Cash Per Share | -0.12 | 0.01 | 0.01 | -0.01 | 0.05 | -0.05 | Upgrade |
Filing Date Shares Outstanding | 583.5 | 583.5 | 583.5 | 583.5 | 583.5 | 583.5 | Upgrade |
Total Common Shares Outstanding | 583.5 | 583.5 | 583.5 | 583.5 | 583.5 | 583.5 | Upgrade |
Working Capital | 416.77 | 324.33 | 416.87 | 418.1 | 389.98 | 392.46 | Upgrade |
Book Value Per Share | 1.23 | 1.16 | 0.99 | 0.99 | 0.95 | 0.93 | Upgrade |
Tangible Book Value | 718.26 | 676.42 | 575 | 579.55 | 556.01 | 540.58 | Upgrade |
Tangible Book Value Per Share | 1.23 | 1.16 | 0.99 | 0.99 | 0.95 | 0.93 | Upgrade |
Machinery | - | 40.25 | 37.65 | 36.3 | 34.93 | 28.75 | Upgrade |
Construction In Progress | - | - | - | - | 4.76 | 20.41 | Upgrade |
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.